Group 1 - The core viewpoint of the news is that普蕊斯 experienced a decline in stock price, dropping by 5.02% to 51.10 CNY per share, with a trading volume of 169 million CNY and a turnover rate of 4.27%, resulting in a total market capitalization of 4.037 billion CNY [1] - 普蕊斯 is a pharmaceutical technology development company established on February 22, 2013, and listed on May 17, 2022, with its main business involving technology development, transfer, consulting, and services in the pharmaceutical field, generating 100% of its revenue from services [1] -融通基金's融通健康产业灵活配置混合A/B fund increased its holdings in普蕊斯 by 100,000 shares in the second quarter, bringing its total to 1 million shares, which represents 1.33% of the circulating shares, with an estimated floating loss of approximately 2.7 million CNY as of the report date [2] Group 2 - The融通健康产业灵活配置混合A/B fund, managed by万民远, has a total asset size of 5.629 billion CNY, with a best fund return of 160.26% and a worst return of -15.45% during his tenure of nearly 10 years [3]
普蕊斯股价跌5.02%，融通基金旗下1只基金位居十大流通股东，持有100万股浮亏损失270万元